We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHV icon
126
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$6.51M 0.19%
59,056
+15,733
+36% +$1.74M
TEVA icon
127
Teva Pharmaceuticals
TEVA
$41.2B
$6.5M 0.19%
179,211
+114,902
+179% +$4.59M
JCI icon
128
Johnson Controls International
JCI
$87.8B
$6.49M 0.19%
157,434
+21,462
+16% +$940K
ULTA icon
129
Ulta Beauty
ULTA
$22.2B
$6.42M 0.19%
25,165
+5,728
+29% +$1.43M
AMC icon
130
AMC Entertainment Holdings
AMC
$2.47B
$6.37M 0.19%
18,935
-100
-0.5% -$32.9K
BRK.A icon
131
Berkshire Hathaway Class A
BRK.A
$1.1T
$6.35M 0.18%
26
+1
+4% +$231K
MA icon
132
Mastercard
MA
$510B
$6.24M 0.18%
60,414
+361
+0.6% +$37.4K
PXD
133
DELISTED
Pioneer Natural Resource Co.
PXD
$6.22M 0.18%
34,550
-1,424
-4% -$261K
ENLK
134
DELISTED
EnLink Midstream Partners, LP
ENLK
$6.21M 0.18%
336,883
-5,684
-2% -$98.9K
NEM icon
135
Newmont
NEM
$101B
$6.14M 0.18%
180,353
-7,944
-4% -$271K
OXY icon
136
Occidental Petroleum
OXY
$55.6B
$6.13M 0.18%
86,047
-8,553
-9% -$607K
PNR icon
137
Pentair
PNR
$10.6B
$6.06M 0.18%
160,848
+6,905
+4% +$269K
APOG icon
138
Apogee Enterprises
APOG
$832M
$6.05M 0.18%
113,000
-47
-0% -$2.18K
CLB icon
139
Core Laboratories
CLB
$477M
$6.05M 0.18%
50,397
-1,971
-4% -$218K
APD icon
140
Air Products & Chemicals
APD
$66.8B
$5.95M 0.17%
41,382
-3,475
-8% -$486K
CAT icon
141
Caterpillar
CAT
$373B
$5.79M 0.17%
62,486
+1,970
+3% +$179K
KKR icon
142
KKR & Co
KKR
$90.7B
$5.78M 0.17%
375,571
+896
+0.2% +$13.5K
ESS icon
143
Essex Property Trust
ESS
$18.1B
$5.71M 0.17%
24,558
-185
-0.7% -$40K
NOC icon
144
Northrop Grumman
NOC
$76B
$5.71M 0.17%
24,532
+758
+3% +$176K
PEG icon
145
Public Service Enterprise Group
PEG
$38.6B
$5.63M 0.16%
128,298
-140
-0.1% -$5.84K
ZTS icon
146
Zoetis
ZTS
$31.9B
$5.58M 0.16%
104,181
-8,797
-8% -$447K
B
147
Barrick Mining
B
$63.2B
$5.52M 0.16%
345,334
+36,125
+12% +$573K
NFLX icon
148
Netflix
NFLX
$305B
$5.51M 0.16%
444,870
-64,470
-13% -$764K
SOXX icon
149
iShares Semiconductor ETF
SOXX
$41.7B
$5.5M 0.16%
134,526
+47,265
+54% +$1.83M
STZ icon
150
Constellation Brands
STZ
$22.3B
$5.49M 0.16%
35,784
-5,227
-13% -$830K

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.